Documentary: Cell & Gene Therapy - Advancing The Next Generation of Pharmaceuticals

Tue, Dec 13, 2022 | By Cryoport Team

In this video documentary, American Pharmaceutical Review and Pharmaceutical Outsourcing magazine spoke with Cryoport Systems' CEO, Mark Sawicki, VP Global BioServices, Rob Jones, and fellow industry...

Through Our Newly Launched Global Supply Chain Centers, Cryoport Systems Now Offers Kit Production

Wed, Nov 30, 2022 | By Cryoport Team

Cryoport combines its expertise in temperature-controlled supply chain solutions to develop a comprehensive offering of vein-to-vein services, one of which includes Kit Production. From clinical to...

Cryoport's Chain of Compliance®: Collects, Interprets, and Leverages Comprehensive Data to Enable a Significantly Smarter Supply Chain

Wed, Oct 19, 2022 | By Cryoport Team

Companies vying to be the first to market with breakthrough treatments have a great deal riding on the success of their efforts. Incorporating innovative processes, ethical considerations, assuring...

Cryoshuttle® Local Delivery and Pickup: Now Serving More Areas

Thu, Oct 13, 2022 | By Cryoport Team

Many biopharmaceutical companies, academic institutions, and manufacturing sites often need to move their valuable life-saving therapies and research materials locally for a variety of reasons, such...

The Cryoport Way: A Leap Forward in Standardizing the Regenerative Medicine Supply Chain

Mon, Aug 29, 2022 | By Cryoport Team

As cell and gene therapies are rapidly moving beyond clinical trials and into commercial markets, the safe and effective delivery of these life-saving treatments needs to be a priority for advanced...

Cryoport Systems’ Global BioServices: Secondary Packaging and Labeling Solutions

Mon, Aug 22, 2022 | By Rob Jones, Vice President of Global BioServices

Cryoport Systems’ highly anticipated Global Supply Chain Centers have been operational for a few months, and customers continue to move biopharmaceutical materials into our Houston, Texas and Morris...

The Untapped Potential for Cord Blood as Allogeneic Starting Material

Wed, Jul 20, 2022 | By Cryoport Team

 In support of Cord Blood Awareness Month, Cryoport Systems’ partner, Be The Match BioTherapies®, led a webinar focused on the untapped potential and benefits of cord blood for prospective therapies....

Cryoport Systems Global Supply Chain Center: Ready for Launch!

Mon, Jun 06, 2022 | By Rob Jones, Vice President of Global BioServices

We are quickly approaching the Grand Opening of our first two Global Supply Chain Centers in Houston, TX on June 14th and Morris Plains, NJ on June 16th, 2022.

Although we are about to officially...

New Product Launch: The Latest Enhancements to Cryoport Express® Standard & Combo Cryogenic Shippers

Thu, May 19, 2022 | By Cryoport Team

At Cryoport Systems, we are continuously striving to align with the latest science and technology advancements in our products and services, integrating the most advanced packaging, informatics, and...

Are You Ready for the Upcoming Data Network Transition? Here's Everything You Need to Know

Fri, Feb 11, 2022 | By Quin Waddell, Director of Monitoring Solutions

The future for global advanced therapy shipments requiring critical near real-time chain of custody, chain of condition and Chain of Compliance® reporting will soon face a significant technology...

2022 Updates to the Harmonized System (HS) and Harmonized Tariff Schedule (HTS)

Wed, Dec 15, 2021 | By Donna Thresher, Director of Global Regulatory Trade and Compliance, Cryoport Systems 

Update: President Biden signed Proclamation 10326 To Modify the Harmonized Tariff Schedule of the United States and for Other Purposes on December 23rd, 2021. Thus, Customs and Border Protection...

Cryoport Systems & CRYOPDP Synergies Provide Integrated and Flexible Temperature-Controlled Supply Chain Solutions for the Life Sciences

Mon, Dec 06, 2021 | By Dave Wilson, Vice President EMEA

Biotech companies continue to innovate cutting-edge therapeutics, and the companies that support their efforts continue to strive for best practices as these new therapies advance and evolve. In the...

Introducing Cryoport BioServices in Morris Plains, NJ ─ A Strategic & Prime Location for Supporting the Life Sciences

Tue, Nov 16, 2021 | By Rob Jones, Vice President of Global BioServices

Cryoport Systems is making significant progress since the last update on launching our Global BioServices in Houston, Texas and Morris Plains, New Jersey. These two prime locations were chosen...

Courier Agnostic – Cryoport Systems’ Great Advantage

Mon, Sep 20, 2021 | By Gregory Stevens, Executive Director - Business Operations

Are you experiencing the following 10 problems with your current logistics courier?

Introducing Cryoport BioServices: Providing a Stronger, Smarter Supply Chain Worldwide

Wed, Sep 08, 2021 | By Rob Jones, Vice President of Global BioServices

One of the challenges facing the cell and gene therapy industry, as it grows and matures, is the development of robust supply chains to support the increase in clinical trials and the...

More Commercial Activity, More Commercial Filings: Good News Ahead for Regenerative Medicine

Fri, Feb 12, 2021 | By Cryoport Team

While the pandemic continues to disrupt many industries, including regenerative medicineit’s not all bad news -- in fact, there are likely some bright spots ahead for the industry this year.

Forbes Honors Cryoport, Inc. on 2021 ‘100 Best Small Companies’ List

Mon, Jan 11, 2021 | By Cryoport Team

2020 was an incredible year of growth for Cryoport, Inc. The acquisitions of CRYOPDP and MVE Biological Solutions dramatically increased our global network and capabilities, and we achieved a new...

Now That A Brexit Deal Has Been Negotiated, Here Is What Cryoport Clients Can Expect

Mon, Dec 28, 2020 | By Donna Thresher, Director of Global Regulatory Trade and Compliance, Cryoport Systems 

Background information

On January 31, 2020, the United Kingdom (UK) officially withdrew from the European Union (EU).   An eleven-month transition period was enacted to negotiate trade terms between...

Cryoport Client Informational Bulletin: Brexit

Wed, Dec 02, 2020 | By Donna Thresher, Director of Global Regulatory Trade and Compliance, Cryoport Systems 

The Brexit transition period is set to expire on December 31, 2020. If you have questions regarding possible outcomes and effects on transporting goods across international borders, please review the...

Cryoport, Inc. By The Numbers: A Year of Record Expansion in 2020

Mon, Nov 30, 2020 | By Ryan Carpentier, Global Vice President -- Business Development, Cryoport Systems

The events of 2020 put unprecedented pressures on the pharmaceutical and logistics industries. As the pandemic lobbed one challenge after the next – cancelled flights, limited flight cargo space,...

What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers

Mon, Nov 16, 2020 | By Rob Jones, Vice President of Global BioServices

You may have heard about the release of ISO 21973:2020, but are wondering what it means. Our experts are here to break it down for you. 

Coronavirus Update: Proactive measures we continue to take

Mon, Nov 16, 2020 | By Cryoport Team

As we approach the annual flu season, Cryoport continues its efforts to proactively monitor the global resurgence of the COVID-19 virus. Cryoport has doubled its efforts to ensure continuity of...

Is Your Supply Chain Partner ISO 9001:2015 Certified? Here’s Why Certification Matters

Tue, Oct 20, 2020 | By Adam Fox, Vice President - Quality Assurance & Regulatory Affairs

Cell and gene therapies may be considered novel by the general public today, but they are on the path to dramatically improve the lives of those with chronic conditions and cancers. While a handful...

How the World’s Biggest Biopharma Companies Manage Increasingly Complex Supply Chain Demands

Mon, Oct 05, 2020 | By Michael Dybicz, Vice President - Consulting Services

Biopharmaceutical supply chains are among the most complex and costly processes on the planet. CAR T-cell therapies, which can cost hundreds of thousands of dollars to create, can be rendered...

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC